Lara Marks
As seen in:
Medium,
The Guardian,
The Telegraph,
Yahoo News Malaysia,
The Conversation,
Quartz,
Medical Xpress,
The Philippine STAR,
Scroll.in,
Reaction
and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Lara Marks
18 Countries in a Year
The second half of 2022. So much for keeping up with my blog. I guess I REALLY had more time on my hands while vanlifing in Australia. Or I was just more ... vigilant? Devoted? Committed? Well, shit. Better late than never. 2022 certainly didn't go as expected. I don't know when anything goes as expected but this was a particularly eventful year. Somehow I ended up visiting 18 different countries. I'm not sure if that's something to brag about, but that's what happened.
COVID variants: we spoke to the experts designing a single vaccine to defeat them all
SARS-CoV-2, the virus responsible for COVID-19, has turned the world upside down. Experts have predicted that it will claim the lives of between 9-18 million worldwide. This is in addition to destroying the livelihoods, mental health and education of countless others. The pandemic will probably wreak havoc for many years to come, despite the remarkable speed of vaccine development.
Explainer: The Covid-19 treatment given to Trump has been cleared in US, India and, now, UK
The United Kingdom medicines regulator has just approved a new Covid-19 treatment. Branded Ronapreve in the UK and REGEN-COV in the United States, the drug was developed by Regeneron Pharmaceuticals with Roche. It first grabbed headlines in October 2020 when United States President Donald Trump received it during his Covid-19 infection.
Ronapreve: new COVID-19 treatment has just been authorised – here's everything you need to know
The UK medicines regulator has just approved a new COVID-19 treatment. Branded Ronapreve in the UK and REGEN-COV in the US, the drug was developed by Regeneron Pharmaceuticals with Roche. It first grabbed headlines in October 2020 when President Trump received it during his COVID-19 infection. Already licensed for emergency use in more than 20 countries – including the US, Japan and India – it is used to treat or prevent acute COVID-19 infection, though isn’t a substitute for vaccination.
Ronapreve: this new treatment for COVID-19 has just been authorised – here's everything you need to know
The UK medicines regulator has just approved a new COVID-19 treatment. Branded Ronapreve in the UK and REGEN-COV in the US, the drug was developed by Regeneron Pharmaceuticals with Roche. It first grabbed headlines in October 2020 when President Trump received it during his COVID-19 infection. Already licensed for emergency use in more than 20 countries – including the US, Japan and India – it is used to treat or prevent acute COVID-19 infection, though isn’t a substitute for vaccination.
A universal COVID-19 vaccine is needed in fight against new variants
SARS-CoV-2, the virus responsible for Covid-19, has turned the world upside down. Experts have predicted that it will claim the lives of between 9-18 million worldwide. This is in addition to destroying the livelihoods, mental health, and education of countless others. The pandemic will probably wreak havoc for many years to come, despite the remarkable speed of vaccine development.
New diagnostic test rapidly identifies bugs responsible for pneumonia Original
Pneumonia is one of the world’s deadliest infectious diseases, killing around 2.6 million people a year. In severe pneumonia, the tiny air sacs inside the lungs become filled with so much fluid and pus that patients struggle to breathe. In many people, this is fatal. Patients can deteriorate very quickly, which means treatment is often given based on the person’s symptoms without knowing the underlying pathogen causing the condition.
Antibiotic resistance: cheap diagnostic test could be a saviour
With the world’s attention focused on combating COVID-19, it is easy to forget the other significant threat to public health and the global economy – the rapid rise of antimicrobial resistance (AMR). Yet the problem has not disappeared. Indeed, the pandemic is probably accelerating it.
Coronavirus: the antibody drugs few people have been discussing - until now
Since the start of the COVID-19 pandemic, researchers have been working around the clock to find an effective treatment. The first drug to show promise is dexamethasone, a cheap, widely available steroid. A large clinical trial run by the University of Oxford showed that the drug cut the risk of death for COVID-19 patients on ventilators by a third, and by a fifth for those on oxygen. Peter Horby, the chief investigator on the trial, described the results as a “major breakthrough”.
The public must speak up about gene editing - beyond embryo modification
Researchers led by the Francis Crick institute recently applied to the Human Fertilisation and Embryology Authority for a licence to genetically modify human embryos. The research would use the genome editing technique CRISPR/Cas9 to shed light on the genetic causes of defect of miscarriages in pregnancy. This is a controversial move, which would make the UK the only country in the world apart from China to carry out such research.
UNESCO's statement on CRISPR/Cas9 highlights the need for public engagement
Dr Camporesi, bioethicist at King's College London (KCL); Dr Marks, historian of medicine, is affiliated to KCL, Cambridge University and UCL and is managing editor of WhatIsBiotechnology.org The UNESCO International Bioethics Committee (IBC) has released a statement reaffirming an earlier moratorium called by a group of US scientists on the use of the CRISPR/Cas9 in human embryos.
International genetics groups advocate germline CRISPR research
Research into human germline genome editing should continue, recommends an international group of 11 human genetics organisations. However, such research should not culminate in human pregnancy until important scientific and ethical questions have been answered.
How DNA detectives are helping solve the rise of superbugs
It is now 12 years since the first set of genetic instructions in a human was sequenced. Many of our hopes for using knowledge about the human genome to better fight the likes of heart disease and cancer still lie years and decades in the future, but DNA sequencing in healthcare is not all about tomorrow. It is already revolutionising clinical microbiology.
Monoclonal antibodies: the invisible allies that changed the face of medicine
They are tiny magic bullets that are quietly shaping the lives of millions of patients around the world. Produced in the lab, invisible to the naked eye, relatively few people are aware of these molecules' existence or where they came from. Yet monoclonal antibodies are contained in six out of ten of the world’s bestselling drugs, helping to treat everything from cancer to heart disease to asthma.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Lara
Contact Lara, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack